Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline prices don’t guarantee quality, and investors should exercise caution as some have shaky business models.
Luckily for you, our mission at StockStory is to help you make money and avoid losses by sorting the winners from the losers. That said, here are three stocks under $50 to swipe left on and some alternatives you should look into instead.
Lindblad Expeditions (LIND)
Share Price: $20.00
Founded by explorer Sven-Olof Lindblad in 1979, Lindblad Expeditions (NASDAQ: LIND) offers cruising experiences to remote destinations in partnership with National Geographic.
Why Do We Steer Clear of LIND?
- Lackluster 16.4% annual revenue growth over the last two years indicates the company is losing ground to competitors
- Subpar operating margin of 5.5% constrains its ability to invest in process improvements or effectively respond to new competitive threats
- Free cash flow margin is not anticipated to grow over the next year
At $20.00 per share, Lindblad Expeditions trades at 818.9x forward P/E. Dive into our free research report to see why there are better opportunities than LIND.
American Airlines (AAL)
Share Price: $12.09
One of the ‘Big Four’ airlines in the US, American Airlines (NASDAQ: AAL) is a major global air carrier that serves both business and leisure travelers through its domestic and international flights.
Why Do We Think AAL Will Underperform?
- Annual sales growth of 1.7% over the last two years lagged behind its consumer discretionary peers as its large revenue base made it difficult to generate incremental demand
- Returns on capital are increasing as management makes relatively better investment decisions
American Airlines is trading at $12.09 per share, or 8x forward EV-to-EBITDA. If you’re considering AAL for your portfolio, see our FREE research report to learn more.
Core Laboratories (CLB)
Share Price: $16.28
With roots dating back to the first commercial oil boom, Core Laboratories (NYSE: CLB) analyzes rock and fluid samples from oil and gas reservoirs to help energy companies optimize production and recovery.
Why Should You Dump CLB?
- Muted 1.6% annual revenue growth over the last five years shows its demand lagged behind its energy upstream and integrated energy peers
- Modest revenue base of $526.5 million gives it less fixed cost leverage and fewer distribution channels than larger companies
- Costly operations and weak unit economics result in an inferior gross margin of 20.7% that must be offset through higher production volumes
Core Laboratories’s stock price of $16.28 implies a valuation ratio of 24.6x forward P/E. Read our free research report to see why you should think twice about including CLB in your portfolio.
Stocks We Like More
ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.
Our AI system flagged Palantir before it ran 1,662%. AppLovin before it ran 753%. Nvidia before it ran 1,178%. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.
